Back to People
Ken Frazier

Ken Frazier

Born 1954 · Age 71

American business executive, long-time Merck & Co. leader (general counsel, president, CEO, executive chairman); led Merck through Vioxx litigation; first African American man to lead a major pharmaceutical company; active board member, philanthropist, and public figure.

Total Events
60
Career Span
68 years
Peak Net Worth
$390,000,000

Compare Your Trajectory

See how your career milestones stack up against Ken Frazier and other industry leaders.

Life & Career Timeline

1954Age 0

Born in North Philadelphia

Kenneth Carleton Frazier is born in Philadelphia, Pennsylvania, to Otis and Clara Frazier.

12/17/1954Source
Confidence
99%
1966Age 12

Mother's death

Frazier's mother, Clara Elizabeth Frazier, dies; he is raised thereafter primarily by his father.

1/1/1966Source
Confidence
96%
1971Age 16

High school graduation and college entry

Graduated high school (attended Julia R. Masterman School and Northeast High) and entered Pennsylvania State University at about age 16.

1/1/1971Source
Confidence
85%
1973Age 18

Raised and sold tadpoles/newts during college

As a Penn State student he raised tadpoles and newts and sold them to local stores to earn extra money.

1/1/1973Net Worth: $1,000Source
Confidence
65%
1975Age 20

Earned B.A. from Pennsylvania State University

Graduated from Penn State with a B.A. (political science/history referenced in interviews).

1/1/1975Net Worth: $2,000Source
Confidence
98%
1975Age 20

Enrolled at Harvard Law School

Matriculated at Harvard Law School after Penn State graduation.

1/1/1975Net Worth: $2,000Source
Confidence
95%
1978Age 23

Received J.D. from Harvard Law School

Graduated from Harvard Law School with a Juris Doctor degree.

1/1/1978Net Worth: $5,000Source
Confidence
99%
1978Age 23

Joined Drinker Biddle & Reath

Started his legal career at the Philadelphia law firm Drinker Biddle & Reath (later became partner there).

1/1/1978Net Worth: $20,000Source
Confidence
98%
1991Age 36

Accepted pro bono death-row case (Cochran)

At the request of the Death Penalty Representation Project, Frazier agreed to represent James Willie 'Bo' Cochran on death-row (pro bono).

1/1/1991Net Worth: $250,000Source
Confidence
95%
1992Age 37

Joined Merck & Co. as a corporate attorney

Left Drinker Biddle & Reath to join Merck's public affairs division as general counsel (vice president, general counsel, and secretary of the Astra Merck group per timeline).

1/1/1992Net Worth: $750,000Source
Confidence
97%
1994Age 39

Named Vice President of Public Affairs at Merck

Took on the role of vice president of public affairs (per Merck/Penn State timeline of roles).

1/1/1994Net Worth: $1,500,000Source
Confidence
88%
1995Age 40

Cochran conviction overturned by appeals court

United States Court of Appeals for the Eleventh Circuit overturned Cochran's conviction after 19 years on death row; Frazier continued representation.

1/1/1995Net Worth: $1,000,000Source
Confidence
95%
1997Age 42

Co-founded Cornerstone Christian Academy (approx.)

Co‑founder and trustee of Cornerstone Christian Academy, a private charter school serving at‑risk youth in Philadelphia (year not specified in sources; approximate entry).

1/1/1997Net Worth: $1,200,000Source
Confidence
25%
1997Age 42

Added responsibilities: assistant general counsel, corporate staff

Assumed additional responsibilities in 1997 as assistant general counsel, corporate staff at Merck.

1/1/1997Net Worth: $2,000,000Source
Confidence
86%
1997Age 42

Cochran retrial leads to acquittal

James Willie 'Bo' Cochran was retried and found not guilty in 1997; Frazier continued representation even after leaving private practice.

1/1/1997Net Worth: $1,200,000Source
Confidence
94%
1999Age 45

Established Penn State scholarship with wife

Kenneth and Andréa Frazier established a scholarship in the liberal arts at Penn State for students who contribute to campus diversity (year cited as 1999).

1/1/1999Net Worth: $12,000,000Source
Confidence
88%
1999Age 44

Promoted to Vice President & Deputy General Counsel (Jan 1999)

Promoted within Merck to vice president and deputy general counsel.

1/1/1999Net Worth: $2,500,000Source
Confidence
92%
1999Age 45

Became Senior Vice President and General Counsel (Dec 1999)

Assumed position overseeing Merck's legal and public affairs functions and The Merck Company Foundation.

12/1/1999Net Worth: $3,000,000Source
Confidence
94%
2001Age 47

Penn State Alumni Fellow Award

Received the Penn State Alumni Fellow Award, a prestigious alumni recognition.

1/1/2001Net Worth: $3,500,000Source
Confidence
92%
2003Age 49

Penn State Distinguished Alumni Award

Received Penn State's Distinguished Alumni Award (highest honor the University bestows).

1/1/2003Net Worth: $5,000,000Source
Confidence
85%
2004Age 50

Association of Corporate Counsel Excellence in Corporate Practice Award

Received the ACC's Excellence in Corporate Practice Award (listed in biographies; year cited in HistoryMakers).

1/1/2004Net Worth: $9,000,000Source
Confidence
78%
2004Age 50

Merck faces Vioxx litigation (liability estimate)

During Frazier's tenure as general counsel Merck faced thousands of suits over Vioxx; analysts estimated potential liability at $20–50 billion.

1/1/2004Net Worth: $8,000,000Source
Confidence
88%
2006Age 51

Promoted to Executive Vice President & General Counsel

Promoted in November 2006 to executive vice president while continuing as general counsel.

1/1/2006Net Worth: $12,000,000Source
Confidence
95%
2007Age 52

Vioxx litigation settled for $4.85 billion

Remaining cases relating to Vioxx were settled in 2007 for approximately $4.85 billion after litigation strategy he directed.

1/1/2007Net Worth: $20,000,000Source
Confidence
97%
2007Age 52

Named head of Human Health business group

Took leadership of Merck's largest group, Human Health, in 2007 (led through 2010 before becoming president).

1/1/2007Net Worth: $15,000,000Source
Confidence
92%
2009Age 54

Joined ExxonMobil board of directors

Appointed to the board of ExxonMobil (serving from 2009 until 2022).

1/1/2009Net Worth: $32,000,000Source
Confidence
95%
2009Age 54

Elected to Penn State Board of Trustees

Became a member of the Penn State Board of Trustees (served as trustee and active supporter of the university).

1/1/2009Net Worth: $30,000,000Source
Confidence
94%
2009Age 54

Equal Justice Initiative Equal Justice Champion Award

Received the Equal Justice Initiative's Equal Justice Champion award (recognition for legal/public service).

1/1/2009Net Worth: $30,000,000Source
Confidence
85%
2010Age 55

Elected by Merck Board as next CEO

Board elected Kenneth Frazier as the next CEO of Merck (date cited in BlackPast/Wikipedia timelines as May 1, 2010).

5/1/2010Net Worth: $50,000,000Source
Confidence
88%
2010Age 55

Named President of Merck

Promoted to President of Merck (May 2010 in multiple timelines), overseeing global human health operations prior to CEO appointment.

5/1/2010Net Worth: $45,000,000Source
Confidence
95%
2011Age 56

Assumed role as Merck CEO and board member

Officially became President and Chief Executive Officer of Merck & Co.; first African-American man to lead a major pharmaceutical company.

1/1/2011Net Worth: $70,000,000Source
Confidence
98%
2011Age 56

Joined PhRMA board (service 2011–2021)

Served on the board of Pharmaceutical Research and Manufacturers of America (PhRMA) from 2011 to 2021.

1/1/2011Net Worth: $260,000,000Source
Confidence
90%
2011Age 56

Chair of Penn State Sandusky investigation

Penn State Board of Trustees appointed Frazier to chair the special committee investigating the Jerry Sandusky child sex‑abuse scandal.

11/11/2011Net Worth: $75,000,000Source
Confidence
96%
2012Age 57

Interviewed by The HistoryMakers

Recorded an extensive oral history interview with The HistoryMakers (digital archive interview date).

8/2/2012Net Worth: $85,000,000Source
Confidence
95%
2013Age 58

Public dispute and apology related to Freeh report criticisms

As Penn State trustee Frazier responded forcefully to criticism of the Freeh Report and later apologized for his outburst (March 2013).

3/1/2013Net Worth: $90,000,000Source
Confidence
90%
2013Age 58

Keynote at American Law Institute Annual Dinner

Delivered the keynote speech at the ALI Annual Dinner (May 2013).

5/1/2013Net Worth: $92,000,000Source
Confidence
92%
2014Age 59

Ranked among highest paid biopharma CEOs

Listed in Equilar/New York Times collaborative lists and ranked among biopharma executives with highest total compensation (2015/2014 reporting context).

1/1/2014Net Worth: $200,000,000Source
Confidence
80%
2014Age 59

Total compensation reported for 2014

Merck reported total compensation for Kenneth Frazier of $21,387,205 for 2014.

1/1/2014Net Worth: $120,000,000Source
Confidence
97%
2015Age 60

Total compensation reported for 2015

Merck reported total compensation for Kenneth Frazier of $17,023,820 for 2015.

1/1/2015Net Worth: $140,000,000Source
Confidence
95%
2016Age 61

Total compensation reported for 2016

Merck reported total compensation for Kenneth Frazier of $21,781,200 for 2016.

1/1/2016Net Worth: $160,000,000Source
Confidence
95%
2016Age 61

Sold 60,000 shares of Merck stock

Sold 60,000 shares at an average price of $64.44 per share (July 2016 reported transaction).

7/1/2016Net Worth: $160,500,000Source
Confidence
90%
2016Age 62

Pension valuation disclosed

As of December 31, 2016, Frazier was eligible for early retirement subsidies with a pension valued at $26,593,261.

12/31/2016Net Worth: $170,000,000Source
Confidence
95%
2017Age 62

Reported Merck stock holdings

Reported ownership of 600,304 shares of Merck stock worth approximately $37,000,000 (reported Feb 26, 2017).

2/26/2017Net Worth: $250,000,000Source
Confidence
89%
2017Age 62

Resigned from President's American Manufacturing Council

Resigned from President Trump's American Manufacturing Council citing objection to administration's response to Charlottesville violence.

8/14/2017Net Worth: $255,000,000Source
Confidence
97%
2018Age 63

Named one of Fortune's World's Greatest Leaders

Recognized by Fortune magazine as one of the World's Greatest Leaders (2018).

1/1/2018Net Worth: $280,000,000Source
Confidence
90%
2018Age 64

Sold significant Merck shares (2018–2020)

Reported sales across 2018, 2019 and 2020: 787,792 shares (2018), 694,698 shares (2019), and 280,000 shares (2020); combined proceeds reported around $110.23 million at time of sale (aggregate reporting).

1/1/2018Net Worth: $340,000,000Source
Confidence
75%
2018Age 63

Elected to the American Philosophical Society

Elected as a member of the American Philosophical Society (2018).

1/1/2018Net Worth: $270,000,000Source
Confidence
95%
2018Age 63

Harvard Law School Association Award

Received the Harvard Law School Association Award (2018) for extraordinary service to the legal profession and public.

1/1/2018Net Worth: $275,000,000Source
Confidence
92%
2018Age 63

Named one of Time's 100 Most Influential People

Included in Time magazine's list of the 100 Most Influential People in the World (2018).

1/1/2018Net Worth: $270,000,000Source
Confidence
98%
2018Age 63

Co‑founded OneTen (co‑chair)

Named Co-Founder and Co-Chair of OneTen, a coalition to upskill and hire one million Black Americans—UCLA bio lists him as co-founder/co-chair (OneTen public launch occurred in 2018).

1/1/2018Net Worth: $280,000,000Source
Confidence
60%
2018Age 63

Member of American Academy of Arts and Sciences and other professional societies

Listed as member of the American Academy of Arts and Sciences, American Philosophical Society, American Law Institute council and Fellow of the College of Physicians of Philadelphia (various honorary/leadership roles).

1/1/2018Net Worth: $280,000,000Source
Confidence
85%
2019Age 64

Forbes Lifetime Achievement Award for Healthcare

Became the first recipient of Forbes' Lifetime Achievement Award for Healthcare (2019).

1/1/2019Net Worth: $300,000,000Source
Confidence
90%
2020Age 65

CNBC Interview on George Floyd and racial injustice

Spoke on CNBC Squawk Box about racial tensions after George Floyd's murder, noting 'it could have been me'.

6/1/2020Net Worth: $350,000,000Source
Confidence
96%
2020Age 65

Donated $5 million to Jefferson Health and Temple partnership

Kenneth and Andréa Frazier donated $5 million to Jefferson Health to support a stroke initiative targeting African‑American communities (reported Aug 2020).

8/1/2020Net Worth: $345,000,000Source
Confidence
96%
2021Age 66

Named again to Time's 100 Most Influential People

Included in Time's list of most influential people in 2021 (second Time recognition mentioned).

1/1/2021Net Worth: $370,000,000Source
Confidence
98%
2021Age 66

Columbia Business School Deming Cup & Chief Executive CEO of the Year

Received the Deming Cup for Operational Excellence (Columbia Business School) and was named Chief Executive magazine's CEO of the Year in 2021.

1/1/2021Net Worth: $375,000,000Source
Confidence
90%
2021Age 66

Announced retirement as Merck President & CEO

Merck announced Frazier would retire as president and CEO at the end of June 2021, while remaining executive chairman.

2/4/2021Net Worth: $360,000,000Source
Confidence
98%
2021Age 66

Became Executive Chairman of Merck's Board

Transitioned to Executive Chairman of Merck's board of directors following retirement as CEO (role began July 2021).

7/1/2021Net Worth: $365,000,000Source
Confidence
96%
2022Age 67

Stepped down from ExxonMobil board

Ended service on the ExxonMobil board (served 2009–2022).

1/1/2022Net Worth: $390,000,000Source
Confidence
92%
2022Age 67

Elected to Eikon Therapeutics Board

Eikon Therapeutics announced Kenneth C. Frazier's election to its board of directors (BusinessWire, March 31, 2022).

1/1/2022Net Worth: $380,000,000Source
Confidence
95%